Principia Wealth Advisory’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35K Sell
55
-66
-55% -$3.58K ﹤0.01% 547
2026
Q1
$7.59K Buy
121
+45
+59% +$3.6K ﹤0.01% 238
2025
Q4
$7.25K Sell
76
-4
-5% -$392 ﹤0.01% 227
2025
Q3
$7.81K Buy
80
+5
+7% +$518 0.01% 224
2025
Q2
$8.06K Sell
75
-1
-1% -$101 0.01% 187
2025
Q1
$7.36K Buy
76
+40
+111% +$4.03K 0.01% 149
2024
Q4
$3.22K Buy
+36
New +$3.17K ﹤0.01% 187

Other funds holding BSX

Principia Wealth Advisory's BSX Position: Q2 2026 in Review

Principia Wealth Advisory reduced its Boston Scientific (BSX) stake by 55% in Q2 2026, selling an estimated $3.58K and leaving 55 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #547.

Principia Wealth Advisory first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.06K in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Principia Wealth Advisory held 55 shares of Boston Scientific worth $2.35K as of Q2 2026.
  • Principia Wealth Advisory sold 66 Boston Scientific shares in Q2 2026, an estimated $3.58K.
  • Boston Scientific made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #547 holding.
  • Principia Wealth Advisory first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Principia Wealth Advisory's Boston Scientific position peaked at $8.06K in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.